News

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
ROCKVILLE, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals ...
February 18, 2025 Supernus' depression treatment fails mid-stage trial, shares plunge Supernus Pharmaceuticals said on Tuesday its depression treatment trial failed to meet the main goal of ...